|
2024
|
Invention
|
Method for preparing intermediate of adrenergic receptor agonist. 3122 are each individually a le... |
|
|
Invention
|
Crystalline forms of a 1h-1,2,3-triazole-4-carboxylic acid compound. The present disclosure provi... |
|
2023
|
Invention
|
Imine reductase mutant, co-expressed recombinant enzyme of imine reductase and glucose dehydrogen... |
|
|
Invention
|
Method for preparing (s)-nicotine by reduction.
A method for preparing (S)-nicotine by reduction... |
|
|
Invention
|
Crystalline forms of a 1h-1, 2, 3-triazole-4-carboxylic acid compound. The present disclosure pro... |
|
2022
|
Invention
|
Method for using reduction to prepare (s)-nicotine. A method for using reduction to prepare (S)-n... |
|
|
P/S
|
Mixing machines; industrial electromechanical marking machine; packaging machines; Machines for m... |
|
|
P/S
|
Mixing machines; industrial marking machine; packaging
machines; machines for pharmaceutical pro... |
|
2021
|
P/S
|
Bases being chemical preparations for use in biochemical and clinical research; salts being chemi... |
|
|
P/S
|
Bases [chemical preparations]; salts [chemical
preparations]; benzene derivatives; alkaloids; ch... |
|
|
Invention
|
Method for synthesizing (s)-nicotine. Provided is a method for synthesizing (S)-nicotine, compris... |
|
|
Invention
|
Method of preparation of (1r,3s)-3-amino-1-cyclopentanol and salt thereof. Provided is a method o... |
|
2019
|
Invention
|
Preparation method for (1r,3s)-3-amino-1-cyclopentanol and salts thereof. A preparation method fo... |
|
2007
|
P/S
|
chemicals for industrial purposes; pharmaceutical intermediates for use in the manufacture of pha... |
